BENZPHETAMINE Drug Patent Profile

Which patents cover Benzphetamine, and what generic alternatives are available?

Benzphetamine is a drug marketed by Avet Lifesciences, Chartwell, Epic Pharma Llc, Impax Labs, Kvk Tech, Scinopharm Taiwan, Specgx Llc, and Tedor Pharm. and is included in nine NDAs.

The generic ingredient in BENZPHETAMINE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Benzphetamine

A generic version of BENZPHETAMINE was approved as benzphetamine hydrochloride by KVK TECH on July 20^th, 2010.

Summary for BENZPHETAMINE

US Patents:	0
Applicants:	8
NDAs:	9
Drug Prices:	Drug price information for BENZPHETAMINE
DailyMed Link:	BENZPHETAMINE at DailyMed

See drug prices for BENZPHETAMINE

US Patents and Regulatory Information for BENZPHETAMINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Avet Lifesciences	BENZPHETAMINE HYDROCHLORIDE	benzphetamine hydrochloride	TABLET;ORAL	202061-001	Jan 27, 2012		DISCN	No	No
Kvk Tech	BENZPHETAMINE HYDROCHLORIDE	benzphetamine hydrochloride	TABLET;ORAL	090968-001	Jul 20, 2010	AA	RX	No	Yes
Epic Pharma Llc	BENZPHETAMINE HYDROCHLORIDE	benzphetamine hydrochloride	TABLET;ORAL	040714-001	Oct 29, 2007		DISCN	No	No
Scinopharm Taiwan	BENZPHETAMINE HYDROCHLORIDE	benzphetamine hydrochloride	TABLET;ORAL	040578-001	Apr 17, 2006		DISCN	No	No
Chartwell	BENZPHETAMINE HYDROCHLORIDE	benzphetamine hydrochloride	TABLET;ORAL	090473-001	Sep 15, 2010		RX	No	No